Ukraine Pharmaceuticals & Healthcare Report Q1 2016 - New Market Report

Ukraine's negative pharmaceutical trade balance will remain and continue to widen to 2019 as the country's political and economic landscapes hamper its local business development. A rising demand for medicines will force the Ukraine to continue seeking its medicine supply from abroad, though the country's severely weak foreign exchange rate will limit revenue-generation for multinational drugmakers.

Headline Expenditure Projections

Pharmaceuticals: UAH40.24bn (USD3.35bn) in 2014 to UAH46.84bn (USD1.95bn) in 2015; +16.4% in local currency terms and -41.7% in US dollar terms. Forecast unchanged from Q 4 1 6 .
Healthcare: UAH114.62bn (USD9.54bn) in 2014 to UAH122.08bn (USD5.09bn) in 2015; +6.5% in local currency terms and -46.7% in US dollar terms. Forecast unchanged from Q 4 1 6 .

Risk/Reward Index

In Q116, Ukraine is ranked as the 19th most attractive market in the Central and Eastern Europe region (scoring 37.4 out of 100). Ukraine's score has collapsed over the previous quarter due to the perilous condition of the country's economy, the depreciation of the local currency against the dollar and the bleak short term outlook.

Full Report Details at
- http://www.fastmr.com/prod/1075349_ukraine_pharmaceuticals.aspx?afid=301

Key Trends & Developments

The Ukraine Pharmaceuticals & Healthcare Report features BMI Research's forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.

BMI's Ukraine Pharmaceuticals & Healthcare Report provides industry professionals, strategists, company executives, investors, analysts and sales/marketing heads with independent forecasts and competitive intelligence on the Ukraine pharmaceutical and healthcare industry.

Key Benefits

* Benchmark BMI's pharmaceutical and healthcare market forecasts for Ukraine, to test other views - a key input for successful budgeting and strategic business planning in the Ukrainian pharmaceutical and healthcare market.
* Target business opportunities and risks in the Ukrainian pharmaceutical and healthcare sector through our reviews of latest industry trends, regulatory changes and major deals, projects and investments in Ukraine.
* Assess the activities, strategy and market position of your competitors using our company profiles (including SWOTs, KPIs and latest activity) and competitive landscape tables.

Coverage

BMI Industry View



About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Kenya Pharmaceuticals & Healthcare Report Q1 2016
- Thailand Pharmaceuticals & Healthcare Report Q1 2016
- Kuwait Pharmaceuticals & Healthcare Report Q1 2016
- Pakistan Pharmaceuticals & Healthcare Report Q1 2016
- Argentina Pharmaceuticals & Healthcare Report Q1 2016